Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership22,480 shares
Latest Disclosed Value $ 523,784
Alps Advisors Inc ownership in HVE / Innoviva, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 22,480 shares of Innoviva, Inc. (DE:HVE) valued at $449,600 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2022 disclosing 0 shares of Innoviva, Inc.. The current value of the position is $431,616 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F INNOVIVA COM 45781M101 22,480 22,480 524 0.0023
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 0 -18,737 -100.00 0 -100.00
2022-08-15 2022-06-30 13F/A-1 INNOVIVA COM 45781M101 18,737 -195 -1.03 277 -24.32 0.0027
2022-08-11 2022-06-30 13F INNOVIVA COM 45781M101 18,737 -195 277 0.0027
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 18,932 -5,488 -22.47 366 -13.06 0.0040
2022-02-09 2021-12-31 13F INNOVIVA COM 45781M101 24,420 317 1.32 421 4.47 0.0047
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 24,103 -4,162 -14.72 403 6.33 0.0039
2021-08-11 2021-06-30 13F INNOVIVA COM 45781M101 28,265 0 0.00 379 12.13 0.0034
2021-05-07 2021-03-31 13F INNOVIVA COM 45781M101 28,265 5,078 21.90 338 17.77 0.0033
2021-02-03 2020-12-31 13F INNOVIVA COM 45781M101 23,187 -472 -2.00 287 16.19 0.0032
2020-11-05 2020-09-30 13F/A-1 INNOVIVA COM 45781M101 23,659 3,203 15.66 247 -13.64 0.0036
2020-11-04 2020-09-30 13F INNOVIVA COM 45781M101 23,659 3,203 247 3,165.6009
2020-08-05 2020-06-30 13F INNOVIVA COM 45781M101 20,456 -2,274 -10.00 286 7.12 0.0038
2020-05-06 2020-03-31 13F INNOVIVA COM 45781M101 22,730 22,730 267 0.0041
2019-11-04 2019-09-30 13F INNOVIVA COMMON STOCK 45781M101 0 -26,804 -100.00 0 -100.00
2019-08-07 2019-06-30 13F INNOVIVA COMMON STOCK 45781M101 26,804 -1,414 -5.01 390 -1.52 0.0029
2019-05-01 2019-03-31 13F INNOVIVA COMMON STOCK 45781M101 28,218 28,218 396 0.0028
2018-10-25 2018-09-30 13F Innoviva COMMON STOCK 45781M101 0 -29,531 -100.00 0 -100.00
2018-08-02 2018-06-30 13F/A-2 Innoviva COMMON STOCK 45781M101 29,531 -1,388 -4.49 408 -20.78 0.0027
2018-07-31 2018-06-30 13F/A-1 Innoviva COMMON STOCK 45781M101 33,949 4,418 482 0.0031
2018-07-25 2018-06-30 13F Innoviva COMMON STOCK 45781M101 33,949 3,030 482
2018-05-01 2018-03-31 13F Innoviva COMMON STOCK 45781M101 30,919 -3,030 -8.93 515 6.85 0.0041
2018-02-20 2017-12-31 13F/A-1 Innoviva COMMON STOCK 45781M101 33,949 1 0.00 482 0.63 0.0033
2018-02-05 2017-12-31 13F Innoviva COMMON STOCK 45781M101 33,949 1 482
2017-11-03 2017-09-30 13F Innoviva COMMON STOCK 45781M101 33,948 -4,284 -11.21 479 -2.04 0.0034
2017-08-03 2017-06-30 13F Innoviva COMMON STOCK 45781M101 38,232 99 0.26 489 -7.21 0.0034
2017-05-12 2017-03-31 13F Innoviva COMMON STOCK 45781M101 38,133 38,133 527 0.0036
2016-05-10 2016-03-31 13F THERAVANCE Common Stock 88338T104 0 0 0 0.0000
2016-02-05 2015-12-31 13F THERAVANCE Common Stock 88338T104 0 -183,337 -100.00 0 -100.00
2015-11-13 2015-09-30 13F Theravance Common Stock 88338T104 183,337 67,360 58.08 13,164 528.05 0.0139
2015-08-12 2015-06-30 13F THERAVANCE Common Stock 88338T104 115,977 58,225 100.82 2,096 130.84 0.0179
2015-05-15 2015-03-31 13F THERAVANCE Common Stock 88338T104 57,752 57,752 908 0.0074
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.